RyvuTx

Ryvu Therapeutics is developing novel small molecule therapies that address clinical limitations of current treatments in oncology.

[RyvuTx @RyvuTx]

This week, conversations around Ryvu’s science will take place not only in Kraków, but also in Chicago during #ASCO2026. From May 29 – June 2, 2026, Vatnak Vat-Ho will represent Ryvu Therapeutics at this event.

[RyvuTx @RyvuTx]

Ryvu Therapeutics reported Q1 2026 financial results and provided a corporate update, highlighting key progress across clinical development, partnerships, and financing.
Read more: https://t.co/M1CAmhAc4l

#RyvuTx #Biotech #Oncology #AML #DrugDiscovery #EHA2026 #RIVER81 #POTAMI61

[RyvuTx @RyvuTx]

This week, Kamil Sitarz from Ryvu will share how to approach this challenge at the 22nd #ClinicalTrials Strategic Summit in Munich, and what can be learned by building it from the inside. If you are attending, come say hello!

[RyvuTx @RyvuTx]

Już 20 maja w Krakowie zapraszamy wszystkich związanych z branżą life science, medycyną, farmacją oraz sympatyków nowoczesnych technologii w ochronie zdrowia na festiwal Pint of Science z udziałem Roberta Dobosza z Ryvu Therapeutics.
Więcej: https://t.co/L1AT3qY8Dm

[RyvuTx @RyvuTx]

Ryvu Therapeutics continues to advance the clinical development of romaciclib (#RVU120) with new Phase II data to be presented at #EHA2026 in Stockholm.

Read more: https://t.co/tSBfN0cIP1

[RyvuTx @RyvuTx]

European biotech has the science and the clinical capability to run complex trials at scale. The question is whether the ecosystem - capital, regulatory frameworks, exit pathways, and the people within it is catching up fast enough. Learn more about our perspective at #OCTEurope

[RyvuTx @RyvuTx]

Central and Eastern Europe is stepping into the spotlight as a catalyst for faster, smarter drug development, and we’re excited to be part of that conversation. Join Kamil Sitarz at #BioEquityEurope

[RyvuTx @RyvuTx]

Vatnak Vat-Ho will be representing Ryvu Therapeutics at #BioEquityEurope 2026! Looking forward to connecting with partners, investors, and innovators to explore opportunities!

[RyvuTx @RyvuTx]

Krzysztof Brzózka and Mateusz Nowak are getting ready for the #Antibody & #ADC Summit in Shanghai.
At Ryvu, ADCs aren’t just a topic we follow. They’re part of what we build. If you’re attending and want to talk ADCs, let’s connect!

[RyvuTx @RyvuTx]

The energy at #AACR Annual Meeting 2026 is in full swing, and we’re proud to be part of it. 🙌 At this year’s meeting in San Diego, we are presenting new preclinical data on our #ONCOPrime platform.

Download the poster ⬇️
https://t.co/k2XkzbcIGo

[RyvuTx @RyvuTx]

Kamil Sitarz will represent Ryvu at the 21st Clinical Trials Strategic Summit (CTSS) 2026 as an expert speaker!
Go to the agenda: https://t.co/c0FQ0jIQjm

#RyvuYx #CTSS2026 #ClinicalTrials #ClinicalOperations #CRO #ClinicalResearch

[RyvuTx @RyvuTx]

The Accelerating Bio-Innovation Conference (ABI) returns to Cambridge on 20–22 April 2026. Vatnak Vat-Ho, CBO at Ryvu Therapeutics, will attend and looks forward to engaging discussions and new connections. 🙌 Connect with him if you’ll be there!

#ABI2026 #Biotech #DrugDiscovery

[RyvuTx @RyvuTx]

In just a few days, our team will be heading to San Diego for the #AACR Annual Meeting 2026! We’re excited to share our latest scientific advances
See you in San Diego! ☀️

[RyvuTx @RyvuTx]

#GPW w Warszawie świętuje swoje 35-lecie 🎉 Prezes Zarządu Ryvu, Paweł Przewięźlikowski weźmie udział w panelu dyskusyjnym pt. "Innowacje", aby podzielić się swoimi doświadczeniami w branży biotech i perspektywą na przyszłość.

[RyvuTx @RyvuTx]

Już jutro Pawel Przewiezlikowski weźmie udział w konferencji pt. „KPO w zdrowiu – inwestujemy dziś, zmieniamy system ochrony zdrowia na lata”.
Wydarzenie organizowane jest przez @MZ_GOV_PL oraz Agencję Badań Medycznych.

[RyvuTx @RyvuTx]

Ryvu is heading to #LogiPharma2026 (April 14–16 in Vienna), and we're proud to share that Kamil Sitarz will deliver the opening keynote at event.

If you're attending LogiPharma 2026, we invite you to join the session and connect with Kamil directly.

[RyvuTx @RyvuTx]

We’re proud to share that Ryvu has been recognized in the prestigious “#GiełdowaSpółkaRoku 2025” ranking. 🎉Among the 140 listed companies, we ranked:
🔟th in the main ranking
5️⃣th in Innovation in products and services
5️⃣th in Management Board competence

[RyvuTx @RyvuTx]

Ryvu w czołówce innowatorów w Polsce! W najnowszym zestawieniu Europejskiego Urzędu Patentowego jesteśmy pierwsi pod względem liczby zgłoszeń patentowych w obszarze odkrywania leków, jednocześnie będąc w pierwszej trójce firm z sektora prywatnego. https://t.co/svsJhrICFZ

[RyvuTx @RyvuTx]

Staying a bit longer in Lisbon after #BIO Europe Spring? It’s also a good opportunity to visit the #LSX World Congress Europe and connect with Pawel Przewiezlikowski. Feel free to reach out!

[RyvuTx @RyvuTx]

Ryvu Therapeutics has reported its financial results for FY2025 and shared a corporate update. Read the press release: https://t.co/uOC4jG0Y6W